scPharmaceuticals to Participate in the 12th Annual LifeSci Partners Corporate Access Event

Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH) announced that CEO John Tucker will participate in the 12th Annual LifeSci Partners Corporate Access Event on January 9-10, 2023, in San Francisco. The company focuses on developing products to optimize infused therapies, improve patient care, and reduce healthcare costs. Their key initiatives aim to facilitate outpatient treatment for acute conditions, particularly in heart failure and infectious diseases through subcutaneous self-administration of IV-strength therapies. More details regarding the event can be found on their website.

BURLINGTON, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to participate in the 12^th Annual LifeSci Partners Corporate Access Event, on Monday, January 9 and Tuesday, January 10, 2023, in San Francisco. Learn more about the event and schedule an in-person meeting with the scPharmaceuticals management here.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com 

FAQ

What event is scPharmaceuticals participating in January 2023?

scPharmaceuticals will participate in the 12th Annual LifeSci Partners Corporate Access Event on January 9-10, 2023.

Who is representing scPharmaceuticals at the LifeSci event?

John Tucker, the CEO of scPharmaceuticals, will represent the company.

What is the focus of scPharmaceuticals' product development?

scPharmaceuticals focuses on optimizing infused therapies and advancing outpatient care for acute conditions.

What therapies is scPharmaceuticals developing?

The company is developing subcutaneous self-administration therapies for heart failure and infectious diseases.

Where is scPharmaceuticals headquartered?

scPharmaceuticals is headquartered in Burlington, Massachusetts.